1. Uncovering potential novel biomarkers and immune infiltration characteristics in persistent atrial fibrillation using integrated bioinformatics analysis
   Shengjue Xiao et al, 2021, Mathematical Biosciences and Engineering CrossRef
2. Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
   Cun-Cun Hua et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
3. Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach
   Luisa Marracino et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
4. Identifying ceRNA Networks Associated With the Susceptibility and Persistence of Atrial Fibrillation Through Weighted Gene Co-Expression Network Analysis
   Yaozhong Liu et al, 2021, Frontiers in Genetics CrossRef
5. MicroRNA-34a in cardiovascular disease: a glimpse into the future
   A.M. Alieva et al, 2023, Kardiologicheskii vestnik CrossRef
6. Glycyrrhetinic acid alleviates atrial fibrillation by inhibiting the expression of PIM1
   Hao Liang et al, 2024, Chemical Biology & Drug Design CrossRef
7. The Role of Circulating MicroRNAs in Cardiovascular Diseases: A Novel Biomarker for Diagnosis and Potential Therapeutic Targets?
   Loredana Iacobescu et al, 2024, Cureus CrossRef
8. Genetic Complexity of Sinoatrial Node Dysfunction
   Michael J. Wallace et al, 2021, Frontiers in Genetics CrossRef